Noticias y Actividades de Novotech
Presencia
Novotech es una empresa que cotiza bajo el símbolo de cotización 285490 (HK).
Ejecutivos
Ver el organigrama con sus 18 ejecutivos principales
Biografías más buscadas en Novotech
- John Moller, Chief Executive Officer
- Elaine Cheung, Independent Non-Executive Director
- Cai Li, Board Member
Recientes movimientos de ejecutivos en Novotech
- Yooni Kim que ha sido Vice President and Global Head of Clinical Services, ha ascendido a Managing Director, Asia Pacific (noticia publicada el 13 de septiembre de 2024).
Crear su alerta
para seguir los movimientos de los ejecutivos en Novotech.
Biotecnología
Novotech tiene 2.351 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Genus (Reino Unido).
Popular M&A news in Biotecnología
- Transcarent and Accolade have merged (publicado el 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar una recaudación de fondos de 150 millones de dólares. (publicado el 7 de abril de 2025).
- Atsena Therapeutics acaba de anunciar una recaudación de fondos de 150 millones de dólares. (publicado el 4 de abril de 2025).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Novotech
- Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials | Novotech CRO
- Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories | Novotech CRO
- Novotech Releases Report on Global Parkinson’s Disease Clinical Trial Landscape | Novotech CRO
- Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development | Novotech CRO
- Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape | Novotech CRO
- Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC) | Novotech CRO
- Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement | Novotech CRO
- The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research | Novotech CRO
- Novotech releases In-Depth Report on Cervical Cancer: Addressing a Global Health Challenge | Novotech CRO
- Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards | Novotech CRO
- View more press releases Close
Redes sociales sobre Novotech
- Novotech en Wikipedia, Google News y Yahoo Finance
- Novotech en LinkedIn, Twitter y YouTube
